Comparison of treatment effect of sodium valprovate, propranolol and tricyclic antidepressants in migraine

Pakistan Journal of Biological Sciences

Volumn 12, Issue 15, 2009, Pages 1098-1101

  Ghasami, K ^a   Mohammad Beigi, Abolfazl ^b  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Encephalogram; Migraine; Sodium valprovate; Tricyclic antidepressants

Indexed keywords

ANTICONVULSIVE AGENT; PROPRANOLOL; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VASODILATOR AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MIGRAINE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; MIGRAINE DISORDERS; PROPRANOLOL; TREATMENT OUTCOME; VALPROIC ACID; VASODILATOR AGENTS;

EID: 70349622752     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2009.1098.1101     Document Type: Article

References (19)

1. Calabresi, P., F. Galletti, C. Rossi, P. Sarchielli and L.M. Cupini, 2007. Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms. Trends Pharmacol. Sci., 28: 188-195.
2. De Lissvoy, G. and S.S. Lazarus, 1994. The economic cost of migraine: present state of knowledge. Neurology, 44: S56-S62.
3. Diamond, S., M.E. Bigal, S. Silberstein, E. Loder, M. Reed and R.B. Lipton, 2007. Patterns of diagnosis and acute preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study. Headache, 47: 355-363.
4. Freitag, F.G., S.D. Collins, H.A. Carlson, J. Goldstein and J. Saper et al., 2002. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology, 58: 1652-1659.
5. Hershey, A.D., S.W. Powers, A.L. Bentti and T.J. De Grauw, 2000. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache, 40: 539-549.
6. Hershey, A.D. and P.K. Winner, 2005. Pediatric migraine: Recognition and treatment. J. Am. Osteopath. Assoc, 105: 2S-8S.
7. Levinstein, B., 1991. A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of adolescent migraine. Cephalalgia, 11: 122-123.
8. Lipton, R.B., W.F. Stewart, S. Diamond, M.L. Diamond and M. Reed, 2001. Prevalence and burden of migraine in the United States: Data from the American migraine study II. Headache, 41: 646-657.
9. Mueller, L.L., 2007. Diagnosing and managing migraine headache. J. Am. Osteopath. Assoc, 107: ES10-16.
10. Owens, C, B. Pugmire and K. Owens, 2008. A migraine prophylaxis educational intervention in a Medicaid population. Headache, 48: 267-271.
11. Pascual, J., M.J. Lainez, D. Dodick andR. Hering-Hanit, 2007. Antiepileptic drugs for the treatment of chronic and episodic cluster headache. Headache, 7: 81-89.
12. Silberstein, S.D., R.B. Lipton and M. Shwinski, 1996. Classification of daily and near-daily headache: A field study of revised IHScriteria. Neurology, 47: 871-875.
13. Silberstein, S.D., 2000. Practice parameter: Evidence-based guidelines for migraine headache (an evidence based review). Rep. Qual. Standards Subcommittee Am. Acad.Neurol.,55: 754-762.
14. Silberstein, S.D., 2006. Preventive treatment of migraine. Trends Pharmacol. Sci., 27: 410-415.
15. Spasic, M., M. Zivkovic and S. Lukic, 2003. Prophylactic treatment of migraine by valproate. Medicine and Biol., 10: 106-110.
16. Stewart, W.F. and R.B. Lipton, 1993. Migraine headache: epidemiology and health care utilization. Cephalalgia, 13: 41-61.
17. Topczewski, A., L. Otavio and S.F. Caboclo, 2008. Valproate-induced acute encephalopathy. Einstein, 6: 86-87.
18. Unalp, A., N. Uranand, A. Ozturk, 2008. Comparison of the effectiveness of topiramate and sodium valproate in pediatric migraine. J. ChildNeurol., 23: 1377-1381.
19. Yurekli, V.A., G. Akhan, S. Kutluhan, E. Uzar, H.R. Koyuncuoglu and F. Gultekin, 2008. The effect of sodium valproate on chronic daily headache and its subgroups. J. Headache Pain, 9: 37-41.